Vishnu Chemicals Limited — Updates, 16-11-2024: Press Release

Vishnu Chemicals Limited reported its Q2FY25 and H1FY25 financial results, highlighting a solid 12.2% year-on-year revenue growth in H1FY25 and 11.6% in Q2FY25, with revenues from operations reaching ₹343.8 crore in Q2. However, the company's consolidated EBITDA margin decreased to 13.1% in Q2, down from 14.9% in the previous year, while the profitability metrics showed a 5% decline in consolidated PAT and a 28.7% drop in standalone PAT, primarily due to rising input costs and administrative expenses related to recent acquisitions.

The domestic sales mix remains favorable at 57:43, reflecting strong domestic demand, though the company remains cautious about export recovery amid global challenges. The balance sheet is robust, with a low debt-to-equity ratio of 0.45 and cash reserves of ₹100.1 crore. Recent strategic acquisitions include Jayansree Pharma and a Chrome Mining Complex in South Africa, anticipated to bolster the company’s market position and operational capacity. Management expresses a positive outlook, leveraging their cash-rich status to navigate current market conditions.